Frontlight ResearchEarly access
Gastric and oesophageal cancer trials in New Zealand
4 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleEIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
- Where
- Roslyn, Wellington
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT07262619 · EU 2026-525248-13-00 - Phase 1Taking peopleIKS014 in Advanced Solid Tumors That Express HER2
- Where
- Auckland
- Age
- 18 years and over
- People
- 165 worldwide
- Run by
- Iksuda Therapeutics Ltd.
See details and how to joinNCT05872295 - Phase 1/2Taking peopleA Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
- Where
- Auckland
- Age
- 18 years and over
- People
- 630 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT06427941 · EU 2025-524136-19-00 - Phase 2Taking peopleA Trial of Palliative Chemotherapy, Radiation and Immune Treatment for Oesophageal Cancer: PALEO Study
- Where
- Grafton
- Age
- 18 years and over
- People
- 54 worldwide
- Run by
- Australasian Gastro-Intestinal Trials Group
See details and how to joinNCT06290505